Pharming Group (OTCMKTS:PHGUF) Shares Gap Up – Here’s What Happened

by · The Markets Daily

Shares of Pharming Group NV (OTCMKTS:PHGUF – Get Free Report) gapped up prior to trading on Wednesday . The stock had previously closed at $1.20, but opened at $1.30. Pharming Group shares last traded at $1.30, with a volume of 20,859 shares traded.

Pharming Group Stock Up 13.0%

The company has a debt-to-equity ratio of 0.40, a current ratio of 2.63 and a quick ratio of 2.06. The stock has a market capitalization of $872.39 million, a PE ratio of 65.03 and a beta of 0.45. The company has a 50 day moving average price of $1.33 and a 200-day moving average price of $1.56.

Pharming Group (OTCMKTS:PHGUF – Get Free Report) last released its quarterly earnings results on Thursday, May 7th. The biotechnology company reported ($0.01) earnings per share for the quarter. The company had revenue of $72.45 million during the quarter, compared to the consensus estimate of $92.06 million. Pharming Group had a net margin of 3.30% and a return on equity of 4.64%.

About Pharming Group

(Get Free Report)

Pharming Group NV is a Netherlands-based biopharmaceutical company specializing in the development and commercialization of protein replacement therapies for rare diseases. Founded in 1988 and headquartered in Leiden, the company leverages transgenic technology to produce recombinant proteins, with its flagship product RUCONEST (recombinant C1 esterase inhibitor) indicated for the treatment of acute hereditary angioedema (HAE) attacks. RUCONEST is approved and marketed in the United States, Europe and several other territories through partnerships with leading specialty pharmaceutical companies.

Beyond RUCONEST, Pharming maintains a diversified pipeline targeting unmet needs in rare and ultra-rare disorders.

Featured Articles